AI-Assisted Clinical Evidence Synthesis Workspace

Speeds literature search screening and extraction for medical affairs and regulatory evidence packages Evidence basis: npj Digital Medicine reported human-AI workflows improved screening recall and reduced evidence synthesis time; benefits were strongest with expert oversight and remaining limits in extraction generalization

The Problem

Clinical evidence synthesis is too slow and labor-intensive for medical affairs and regulatory timelines

Organizations face these key challenges:

1

Manual screening and extraction consume expert time

2

Risk-of-bias assessment is repetitive but requires trained judgment

3

Search strategy development and topic scoping are slow and inconsistent

4

Living reviews create constant rework as new studies appear

5

Extraction quality varies across reviewers and vendors

6

Auditability and source traceability are difficult to maintain in spreadsheets

7

Complex real-world evidence interpretation requires nuanced attribution beyond simple summarization

8

Regulatory and medical affairs teams need defensible outputs, not black-box automation

Impact When Solved

Shortens literature search, screening, and extraction timelines for evidence packagesImproves reviewer productivity while preserving expert oversightSupports living systematic reviews with continuous update workflowsCreates traceable links from extracted fields and judgments back to source passagesStandardizes risk-of-bias and extraction workflows across therapeutic areasEnables faster evidence generation for launch readiness, label support, and medical response content

The Shift

Before AI~85% Manual

Human Does

  • Define evidence questions and inclusion criteria
  • Manually screen literature search results for relevance
  • Extract study details and outcomes into shared trackers
  • Review evidence summaries and resolve inconsistencies

Automation

  • No AI-assisted screening or extraction support
  • No automated prioritization of relevant studies
  • No system-generated evidence summaries or flags
With AI~75% Automated

Human Does

  • Set review scope, evidence standards, and decision criteria
  • Validate AI-prioritized studies and confirm inclusion decisions
  • Review extracted evidence fields and correct exceptions

AI Handles

  • Prioritize literature search results for screening review
  • Flag potentially relevant studies based on evidence criteria
  • Draft structured extraction of study characteristics and outcomes
  • Generate evidence summary views for expert review

Operating Intelligence

How AI-Assisted Clinical Evidence Synthesis Workspace runs once it is live

AI runs the first three steps autonomously.

Humans own every decision.

The system gets smarter each cycle.

Confidence92%
ArchetypeRecommend & Decide
Shape6-step converge
Human gates1
Autonomy
67%AI controls 4 of 6 steps

Who is in control at each step

Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.

Loop shapeconverge

Step 1

Assemble Context

Step 2

Analyze

Step 3

Recommend

Step 4

Human Decision

Step 5

Execute

Step 6

Feedback

AI lead

Autonomous execution

1AI
2AI
3AI
5AI
gate

Human lead

Approval, override, feedback

4Human
6 Loop
AI-led step
Human-controlled step
Feedback loop
TL;DR

AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.

The Loop

6 steps

1 operating angles mapped

Operational Depth

Technologies

Technologies commonly used in AI-Assisted Clinical Evidence Synthesis Workspace implementations:

Key Players

Companies actively working on AI-Assisted Clinical Evidence Synthesis Workspace solutions:

Real-World Use Cases

LLM-assisted risk-of-bias assessment in evidence synthesis

Use a language model to help judge whether a clinical study may be biased, so reviewers can assess study quality faster.

Structured judgment extraction and multi-domain classificationearly-stage assistive workflow: useful for some bias domains, but inconsistent accuracy means expert oversight remains necessary.
10.0

Interdependence-aware attribution of semaglutide real-world weight-loss outcomes

This workflow breaks a patient’s observed weight loss into pieces to estimate how much likely came from the drug versus things like staying on therapy, lifestyle support, care intensity, and dose titration, while accounting for the fact that these factors influence each other.

causal-style outcome decomposition and counterfactual attribution under dependent covariatesproposed/applied case-study workflow with concrete example outputs, but not presented as a broadly deployed commercial standard.
10.0

Collaborative LLM workflow for automated data extraction in living systematic reviews

Two AI reviewers read clinical trial papers, compare answers, and challenge each other when they disagree so researchers can update evidence reviews faster.

multi-agent extraction with adjudicationproposed and experimentally validated on a small held-out dataset; promising but not yet production-proven at scale.
10.0

Streamlining initial systematic review development tasks with AI

AI helps with the first part of a systematic review—figuring out the topic and finding relevant papers—so researchers can move faster before doing the detailed manual review work.

workflow augmentation for research discoveryassistive and targeted; suitable for streamlining specific review stages, not presented as end-to-end systematic review automation.
10.0

Free access to this report